Surmodics will be acquired by GTCR for $43.00 per share, totaling $627 million. This 41.1% premium reflects Surmodics' advancements in surface modification for medical devices and IVD technologies.
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.
Companies Reporting Before The Bell
• ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter.
• Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on revenue of $75.66 billion.